Expert Opinion on Pharmacotherapy

Papers
(The H4-Index of Expert Opinion on Pharmacotherapy is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Perspectives on the pharmacological management of dystonia52
Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer35
Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis35
Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus34
Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges29
Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis28
GLP-1 receptor agonists: new kids in the block of renoprotection for people with type 2 diabetes and chronic kidney disease28
Fixed-dose combination amlodipine–celecoxib for treatment of hypertension and osteoarthritis pain: an up-to-date evaluation28
Sodium–glucose cotransporter 2 inhibitors for the management of type 2 diabetes27
An update on emerging pharmacological treatments for meibomian gland dysfunction25
The pharmacotherapeutic management of pulmonary tuberculosis: an update of the state-of-the-art25
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement24
Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients23
The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular disease22
Pharmacotherapy developments in autophagy inhibitors for bladder cancer21
An overview of cilastatin + imipenem + relebactam as a therapeutic option for hospital-acquired and ventilator-associated bacterial pneumonia: evidence to date21
The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration21
Immunosuppression in uterus transplantation: from transplant to delivery20
Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature20
Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario20
0.02895712852478